The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia

African Journal of Urology

Table 5 Comparison between the change in QOl in group A and group B

		Mean rank	P-value
Quality of life (before)	Tamsulosin only	100.37	0.970
Quality of life (before)	Tamsulosin plus solifenacin	100.63	0.970
Quality of life (after)	Tamsulosin only	138.98	< 0.001
Quality of life (after)	Tamsulosin plus solifenacin	62.02	< 0.001

P value	Mean rank
0.970	100.37	Tamsulosin only	Quality of life (before)
0.970	100.63	Tamsulosin plus solifenacin	Quality of life (before)
< 0.001	138.98	Tamsulosin only	Quality of life (after)
< 0.001	62.02	Tamsulosin plus solifenacin	Quality of life (after)